rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-14
|
pubmed:abstractText |
Laser activated gold nanoshell thermal ablation represents a new, minimally invasive technology that offers benign tissue sparing thermal ablation of malignant tumors. We evaluated the efficacy of this technology for eradicating prostate cancer in a subcutaneous tumor model.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1527-3792
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
179
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
748-53
|
pubmed:meshHeading |
pubmed-meshheading:18082199-Animals,
pubmed-meshheading:18082199-Disease Models, Animal,
pubmed-meshheading:18082199-Electrocoagulation,
pubmed-meshheading:18082199-Gold,
pubmed-meshheading:18082199-Laser Therapy,
pubmed-meshheading:18082199-Male,
pubmed-meshheading:18082199-Metal Nanoparticles,
pubmed-meshheading:18082199-Mice,
pubmed-meshheading:18082199-Mice, Nude,
pubmed-meshheading:18082199-Prostatic Neoplasms
|
pubmed:year |
2008
|
pubmed:articleTitle |
Selective prostate cancer thermal ablation with laser activated gold nanoshells.
|
pubmed:affiliation |
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|